SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$4.78
-5.63%
Mkt Cap $502.47M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+433.5%
Consensus $25.50 vs current $4.78
NASDAQ·Healthcare·Biotechnology
$4.78
-5.63%
Mkt Cap $502.47M
Buy
3
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
+433.5%
Consensus $25.50 vs current $4.78